These secreted proteins are also considered as new therapeutic agents or as targets for small molecule or antibody drug development (14)—for example, anterior gradient-2 (AGR2) is a secreted protein reported to be highly expressed in a variety of tumor types. Here, AGR2 is linked to neoplasm.